Hi Everyone,
I hope you are all keeping well. I still believe that this $80 million CR is for GOOD reason & forward thinking by the company. So much is happening & changing quickly in the Immunology-Oncology space.
Just wanted to put this article out there for people who may have been so focused on the CR shenanigans they might have missed this:
https://www.fiercepharma.com/pharma/esmo-roche-spots-big-untouched-newly-diagnosed-lung-cancer-market-tecentriq-monotherapy
You will see the significance when you read it. Not a lot of time today to post but in NSCLC trial with PD1-VAXX in combination with Tecentriq we are embarking on now.
If no increased safety & toxicity & improved efficacy over Tecentriq as a monotherapy with PD1-VAXX, then great!
Roche supply agreement with IMU for this trial, they have the Monotherapy data for Tecentriq & PD1-VAXX (Monotherapy dose escalation Ph1). The patients who can’t tolerate chemo…Maybe some hope for them early on now.
GLTAH, happy to discuss time permitting, but I thought this was VERY significant to our PD1-VAXX trial/s.
Media Thread, page-6614
-
- There are more pages in this discussion • 8,752 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.9¢ |
Change
-0.003(4.84%) |
Mkt cap ! $433.6M | |||
| Open | High | Low | Value | Volume |
| 6.1¢ | 6.3¢ | 5.9¢ | $2.254M | 37.16M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 37 | 2893846 | 5.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.9¢ | 2258200 | 14 |
View Market Depth
| Last trade - 14.06pm 04/09/2024 (20 minute delay) ? |
| IMU (ASX) Chart |